146 related articles for article (PubMed ID: 10189057)
1. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Volke V; Ustav M; Männistö PT; Bourin M; Vasar E
Neuropeptides; 1998 Jun; 32(3):235-40. PubMed ID: 10189057
[TBL] [Abstract][Full Text] [Related]
2. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone.
Bourin M; Malinge M; Colombel MC; Vasar E
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):37-43. PubMed ID: 10082226
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
[TBL] [Abstract][Full Text] [Related]
5. Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.
Harro J; Põld M; Vasar E
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):62-7. PubMed ID: 2314484
[TBL] [Abstract][Full Text] [Related]
6. Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze.
Vasar E; Peuranen E; Oöpik T; Harro J; Männistö PT
Psychopharmacology (Berl); 1993; 110(1-2):213-8. PubMed ID: 7870888
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin and morphine-induced hypothermia.
Rezayat M; Ravandeh N; Zarrindast MR
Eur Neuropsychopharmacol; 1999 Mar; 9(3):219-25. PubMed ID: 10208291
[TBL] [Abstract][Full Text] [Related]
8. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
9. The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.
Chopin P; Briley M
Psychopharmacology (Berl); 1993; 110(4):409-14. PubMed ID: 7870910
[TBL] [Abstract][Full Text] [Related]
10. Further studies on the role of cholecystokinin-A and B receptors in secretion of anterior pituitary hormones in male rats.
Peuranen E; Vasar E; Koks S; Volke V; Lang A; Rauhala P; Männistö PT
Neuropeptides; 1995 Jan; 28(1):1-11. PubMed ID: 7746348
[TBL] [Abstract][Full Text] [Related]
11. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
[TBL] [Abstract][Full Text] [Related]
12. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.
Rex A; Barth T; Voigt JP; Domeney AM; Fink H
Neurosci Lett; 1994 May; 172(1-2):139-42. PubMed ID: 8084519
[TBL] [Abstract][Full Text] [Related]
13. Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein.
Vasar E; Peuranen E; Harro J; Lang A; Oreland L; Männistö PT
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):96-101. PubMed ID: 8397343
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
[TBL] [Abstract][Full Text] [Related]
15. Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats.
Biró E; Penke B; Telegdy G
Neuropeptides; 1997 Jun; 31(3):281-5. PubMed ID: 9243526
[TBL] [Abstract][Full Text] [Related]
16. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
Bertoglio LJ; Zangrossi H
Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
[TBL] [Abstract][Full Text] [Related]
17. Possible role of cholecystokinin-A receptors in regulation of thyrotropin (TSH) secretion in male rats.
Männistö PT; Peuranen E; Harro J; Vasar E
Neuropeptides; 1992 Dec; 23(4):251-8. PubMed ID: 1475033
[TBL] [Abstract][Full Text] [Related]
18. Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze.
Rex A; Fink H; Marsden CA
Neuropharmacology; 1994; 33(3-4):559-65. PubMed ID: 7527129
[TBL] [Abstract][Full Text] [Related]
19. Effects of cholecystokinin receptor agonist and antagonists on morphine dependence in mice.
Zarrindast MR; Malekzadeh A; Rezayat M; Ghazi-Khansari M
Pharmacol Toxicol; 1995 Dec; 77(6):360-4. PubMed ID: 8835359
[TBL] [Abstract][Full Text] [Related]
20. Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the delta opioid system in the nucleus accumbens of rat.
Daugé V; Samir A; Cupo A; Roques BP
Neuropharmacology; 1999 Jul; 38(7):999-1007. PubMed ID: 10428418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
